Enplace
Device Urogynecologic Pelvic Floor Repair
PDI 07290017082028
General payments
$192,252
Research payments
$2,100
Through program year 2025, $192,252 in general payments and $2,100 in research payments were reported against Enplace (Urogynecologic Pelvic Floor Repair).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $70,343 | 316 |
| 2024 | General | $65,199 | 193 |
| 2023 | General | $32,079 | 149 |
| 2023 | Research | $700 | 2 |
| 2022 | General | $24,631 | 38 |
| 2022 | Research | $1,400 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 24 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
696 general · 5 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.